http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113633678-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
filingDate | 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113633678-B |
titleOfInvention | Application of magnolia sieboldii branch and leaf extract and fluconazole in preparation of antifungal drugs |
abstract | The invention relates to an application of magnolia sieboldii branch and leaf extract and fluconazole in preparation of antifungal drugs, wherein the magnolia sieboldii branch and leaf extract is 75-85% ethanol extract of magnolia sieboldii branches and leaves, and fungi are candida albicans. The 75-85% ethanol extract of the branches and leaves of the magnolia sieboldii provided by the invention can cooperate with the fluconazole drug-resistant candida albicans, provides a new idea for expanding the clinical application of the magnolia sieboldii and treating the fluconazole drug-resistant candida albicans, and provides a reference for combined drug treatment of fungal infection and expanding the clinical application of the magnolia sieboldii. |
priorityDate | 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.